R. Dadmarz

Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.

S. Rosenberg, A. Mixon, D. Schwartzentruber, 1996, The cancer journal from Scientific American.

CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

S. Rosenberg, M. Sgagias, D. Schwartzentruber, 2005, Cancer Immunology, Immunotherapy.

CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

S. Rosenberg, M. Sgagias, R. Dadmarz, 2005, Cancer Immunology, Immunotherapy.

Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation

J. Cawley, R. Dadmarz, 1988, British journal of haematology.

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.

S. Steinberg, S. Rosenberg, S. Topalian, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia.

S. Cannistra, A. Freedman, L. Nadler, 1990, Blood.

The mechanism of action of interferon-α (IFN-α) in hairy-cell leukaemia; Hu-IFN-α2 receptor expression by hairy cells and other normal and leukaemic cell types

J. Cawley, D. Secher, R. Dadmarz, 1986 .

CD23 ANTIGEN EXPRESSION IN CLL

J. Cawley, H. Kronenberg, D. Joshua, 1989, British journal of haematology.

Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.

S. Golub, D. Bockstoce, R. Dadmarz, 1994, Lymphokine and cytokine research.